Colon epithelial barrier state in children with varios types of ulcerative colitis clinical forms

Authors

DOI:

https://doi.org/10.15574/PP.2021.85.53

Keywords:

ulcerative colitis, children, epithelial barrier, mucins, clubs

Abstract

Purpose — analyse the state of the epithelial barrier of the colon in children with different clinical forms. Materials and methods. 42 children with acute chronic colitis were examined, including 28 with ulcerative colitis (14 with active total form, 14 with moderately active segmental); and 14 with chronic non-specific opaque colitis formed a comparison group. Laboratory methods were performed on all patients — hemogram, protein-gram, blood biochemistry, fecal calprotectin concentration; endoscopic examination with biopsy of all colon regions and histological examination of biopts.

Results. The clinical manifestations of ulcerative colitis (UC) during the acute period were assessed by the Paediatric Activity Index (PUCAI) and depended on the localization and activity of the inflammatory process. The average for active colitis was found to be 50.2±1.8, moderate to 35.3±1.7, minimum to 24.1±1.2, but for children with total active inflammation 19 per cent of patients had the highest rates: 65, which corresponded to clinical signs of ulcerative colitis, accompanied by unidirectional changes of surface (dystrophic changes of epithelium, crypt deformation, reduced number of flax cells) and deep (diffuse inflammatory infiltration of its own plate, presence of crypt abscesses, cryptites, vascular dilation) structures of the mucous membrane of the large intestine, which are more pronounced in the active total forms of ulcerative colitis. The period of UC exacerbation is characterized by the violation of the epithelial barrier mucous membrane colon due to reduced mucus synthesis and changes

in its biochemical properties, low secretory (MUC2) and membrane-associated (MUC4) expression Mucins, mainly in the active total forms of UC, loss of the regulatory effect of the club peptide on regeneration and protection of the mucous membrane of the intestine.

Conclusions. Studies based on a pathogenetic approach to determining the cause of the exacerbation of the disease have shown evidence of a significant role in the epithelial barrier of the colon membrane, This is a significant addition to the known knowledge of ulcerative colitis pathogenesis in childhood.

The research was carried out in accordance with the principles of the Helsinki Declaration. The study protocol was approved by the Local Ethics Committee of these Institutes. The informed consent of the patient was obtained for conducting the studies.

The authors declare no conflicts of interests.

References

Aamann L et al. (2014, Mar 28). Trefoil factors in inflammatory bowel disease. World J Gastroenterol. 20 (12): 3223–3330. https://doi.org/10.3748/wjg.v20.i12.3223; PMid:24696606 PMCid:PMC3964394.

Birg TM i dr. (2015). Endoskopicheskie i morfologicheskie sopostavleniya pri vospalitelnyih zabolevaniyah kishechnika. Koloproktologiya. 51 (1): 97–98.

Chernega NV, Denisova MF, Muzika NM, Bukulova NYu. (2017). Yakist zhyttia ditei, khvorykh na vyrazkovyi kolit. Suchasna hastroenterolohiia. 6: 7–11.

Chirkova ML, Kostyukevich SV. (2018). Epiteliy slizistoy obolochki Tolstoy kishki v norme i pri vospalitelnyih zabolevaniyah kishechnika. Eksperimentalnaya i klinicheskaya gastroenterologiya. 153 (5): 128–132.

Denysova MF. (2020). Vyrazkovyi kolit ta dity — skladne pytannia diahnostyky ta likuvannia. Zdorovia Ukrainy. Pediatriia. 1 (52): 10–11.

Dharmni P et al. (2009). Role of intestinal mucins in innate host defense mechanisms against pathogens. J Innate Immun. 1: 123–135. https://doi.org/10.1159/000163037; PMid:20375571 PMCid:PMC7312850

Dorofeev AE, Vasilenko IV, Rassohina OA. (2013). Izmeneniya ekspressii MUC2, MUC3, MUC4, TFF3 v slizistoy obolochke tolstogo kishechnika u bolnyih nespetsificheskim yazvennyim kolitom. Gastroenterolodiya. 1 (47): 80–84.

Droy MT, Drouet Y, Geraund G, Schatz B. (1985). Cytoprotection intestinale. Gastroenterol Clin Biol. 9 (12Pt2): 37–44.

Hensel KO et al. (2014). Differential expression of mucosal trefoil factors and mucins in pediatric inflammatory bowel diseases. Sci Rep. 4: 7343. https://doi.org/10.1038/srep07343; PMid:25475414 PMCid:PMC4256710

Kondo S et al. (2018). Downregulation of trefoil factor-3 expression in the rectum is associated with the development of ulcerative colitis-associated cancer. Oncol Lett. 16 (3): 3658-3664. https://doi.org/10.3892/ol.2018.9120

Lukyanova EM, Denisova MF. (2004). Yazvennyiy kolit u detey (klinika, diagnostika, lechenie). Kiev: 78.

McGuckin MA et al. (2009). Intestinal barrier dysfunction in inflammatory bowel diseases. Inflamm Bowel Dis. 15: 100-113. https://doi.org/10.1002/ibd.20539; PMid:18623167

Nakov R et al. (2019, Jan). Serum trefoil factor 3 predicts disease activity in patients with ulcerative colitis. Eur Rev Med Pharmacol Sci. 23 (2): 788-794. doi: 10.26355/eurrev-201901-16893.

Olen O еt al. (2019). Increased Mortality of Patients With Childhood-Onset inflammatory Bowel Diseases, Compared With the General Population. Castroenterology. 156 (3): 614-622. https://doi.org/10.1053/j.gastro.2018.10.028; PMid:30342031

Orlinskaya NYu i dr. (2018). Znachenie morfologicheskih issledovaniy pri vospalitelnyih zabolevaniyah kishechnika u detey. Meditsinskiy almanah. 3 (54): 31-35.

Perez Vilar J. (2007). Mucin granule intraluminal organization. Am J Respir Cell Mol Biol. 36 (2): 183-190. https://doi.org/10.1165/rcmb.2006-0291TR; PMid:16960124 PMCid:PMC2176109

Shestopalov VA i dr. (2019). Trefoilovyie faktoryi - novyie markeryi mukozalnogo barera zheludochno-kishechnogo trakta. Infektsiya I immunitet. 9 (1): 39-46. https://doi.org/10.15789/2220-7619-2019-1-39-46

Shishkin MA. (2019). MUC1, MUC2, MUC4, MUC5AC, Cdx2: harakteristika immunogistohimicheskoy ekspressii v polipah i adenokartsinome distalnyih otdelov tolstogo kishechnika. Patolohiia. 16 (1): 73-80. https://doi.org/10.14739/2310-1237.2019.1.166313

Shumilov PV i dr. (2010). Klinicheskoe znachenie pristenochnoy mikrofloryi u detey s nespetsificheskim yazvennyim kolitom. Pediatricheskaya farmakologiya. 7 (5): 71-76.

Silva LC et al. (2020). Quality of Life in Children and Adolescents with Inflammatory Bowel Disease: Impact and Predictive Factors. Pediatr Gastroenterol Hepatol Nutr. 23 (3): 286-296. https://doi.org/10.5223/pghn.2020.23.3.286; PMid:32483550 PMCid:PMC7231741

Srivastava S et al. (2015). Serum human trefoil factor 3 is a biomarker for mucosal healing in ulcerative colitis patients with minimal disease activity. J Crohns Colitis. 9 (7): 575-579. https://doi.org/10.1093/ecco-jcc/jjv075; PMid:25964429

Suvorova GN i dr. (2018). Gistologicheskaya kartina i mikrobniy peyzazh pri yazvennom kolite. Vestnik novih meditsinskih tehnologiy. 25 (4): 170–175.

Vasilenko IV. (2010). Morfologicheskaya diagnostika nespetsificheskogo yazvennogo kolita. Gazeta «Novosti meditsinyi i faktoryi». Gastroenterologiya: 313. URL: http://www.mif-ua.com/archive/article/11922.

Zolotova NA, Makarova OV. (2016). Barernaya rol mutsinov tolstoy kishki v norme i pri yazvennom kolite. Klinicheskaya i eksperimentalnaya morfologiya. 3 (19): 69–74.

Zolotova NA. (2014). Strukturnaya i funktsionalnaya harakteristika mutsinov. Klinicheskaya i eksperimentalnaya morfologiya. 1 (9): 66–72.

Published

2021-03-21